Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery.

Kushal D NaikBryan A WhitsonEric M McLaughlinNancy B MatreAlan J Rozycki

Published in: Journal of cardiac surgery (2022)

Apixaban and rivaroxaban demonstrated similar safety when compared to a matched cohort of warfarin patients. Larger prospective randomized studies are needed to confirm these findings.

Keyphrases

atrial fibrillation
venous thromboembolism
direct oral anticoagulants
end stage renal disease
oral anticoagulants
ejection fraction
newly diagnosed
chronic kidney disease
pulmonary embolism
peritoneal dialysis
prognostic factors
open label
placebo controlled
phase iii
patient reported